Children's Hospital Oakland Research Institute, Oakland, CA, USA.
Oncogene. 2017 Jun 29;36(26):3772-3780. doi: 10.1038/onc.2017.12. Epub 2017 Mar 6.
Human basal cell carcinomas (BCCs) very frequently carry p53 mutations, and p53 loss markedly accelerates murine BCC carcinogenesis. We report here our studies of the mechanism by which p53 is activated to suppress BCC carcinogenesis. We find that aberrant hedgehog signaling in microscopic BCCs activates p53 in part via Arf (that is, the oncogene-induced stress pathway) but not via the DNA damage response pathway. However, Arf loss and p53 loss produce differing outcomes-loss of p53 promotes both tumor initiation and progression; loss of Arf promotes tumor progression but not initiation. Intriguingly, increased expression of Arf in tumor stromal cells, as in tumor keratinocytes themselves, contributes to suppression of BCC carcinogenesis.
人类基底细胞癌 (BCC) 非常频繁地携带 p53 突变,而 p53 的缺失显著加速了小鼠 BCC 的致癌作用。我们在此报告我们关于 p53 被激活以抑制 BCC 癌变的机制的研究。我们发现,微观 BCC 中的异常 Hedgehog 信号传导部分通过 Arf(即癌基因诱导的应激途径)而不是通过 DNA 损伤反应途径激活 p53。然而,Arf 的缺失和 p53 的缺失产生了不同的结果——p53 的缺失促进了肿瘤的起始和进展;而 Arf 的缺失促进了肿瘤的进展但不促进肿瘤的起始。有趣的是,肿瘤基质细胞中 Arf 的表达增加,如肿瘤角质形成细胞本身,有助于抑制 BCC 的癌变。